Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 1
2013 1
2014 1
2015 2
2016 2
2017 4
2018 2
2019 2
2020 3
2021 1
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis of hyperferritinemia in routine clinical practice.
Lorcerie B, Audia S, Samson M, Millière A, Falvo N, Leguy-Seguin V, Berthier S, Bonnotte B. Lorcerie B, et al. Among authors: leguy seguin v. Presse Med. 2017 Dec;46(12 Pt 2):e329-e338. doi: 10.1016/j.lpm.2017.09.028. Epub 2017 Nov 20. Presse Med. 2017. PMID: 29150231 Review.
Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trial.
Dupuis-Girod S, Rivière S, Lavigne C, Fargeton AE, Gilbert-Dussardier B, Grobost V, Leguy-Seguin V, Maillard H, Mohamed S, Decullier E, Roux A, Bernard L, Saurin JC, Saroul N, Faure F, Cartier C, Altwegg R, Laccourreye L, Oberti F, Beaudoin M, Dhelens C, Desvignes C, Azzopardi N, Paintaud G, Hermann R, Chinet T. Dupuis-Girod S, et al. Among authors: leguy seguin v. J Intern Med. 2023 Dec;294(6):761-774. doi: 10.1111/joim.13714. Epub 2023 Aug 23. J Intern Med. 2023. PMID: 37592715 Clinical Trial.
Iodoacetamide blank compensation in FXIII functional assays: Is it still necessary?
Savard P, Leguy-Seguin V, Chavy C, Genre-Volot F, Callegarin A, Amiral J, Bonnotte B, Lecompte T, de Maistre E. Savard P, et al. Among authors: leguy seguin v. Int J Lab Hematol. 2023 Dec;45(6):969-971. doi: 10.1111/ijlh.14111. Epub 2023 Jun 8. Int J Lab Hematol. 2023. PMID: 37293692 No abstract available.
Venous thromboembolic events during warm autoimmune hemolytic anemia.
Audia S, Bach B, Samson M, Lakomy D, Bour JB, Burlet B, Guy J, Duvillard L, Branger M, Leguy-Seguin V, Berthier S, Michel M, Bonnotte B. Audia S, et al. Among authors: leguy seguin v. PLoS One. 2018 Nov 8;13(11):e0207218. doi: 10.1371/journal.pone.0207218. eCollection 2018. PLoS One. 2018. PMID: 30408135 Free PMC article.
Sphingosine-1-Phosphate Levels Are Higher in Male Patients with Non-Classic Fabry Disease.
Mauhin W, Tebani A, Amelin D, Abily-Donval L, Lamari F, London J, Douillard C, Dussol B, Leguy-Seguin V, Noel E, Masseau A, Lacombe D, Maillard H, Bekri S, Lidove O, Benveniste O. Mauhin W, et al. Among authors: leguy seguin v. J Clin Med. 2022 Feb 24;11(5):1233. doi: 10.3390/jcm11051233. J Clin Med. 2022. PMID: 35268324 Free PMC article.
Coagulation Parameters in Adult Patients With Type-1 Gaucher Disease.
Serratrice C, Cherin P, Lidove O, Noel E, Masseau A, Leguy-Seguin V, Jaussaud R, Marie I, Lavigne C, Maillot F. Serratrice C, et al. Among authors: leguy seguin v. J Hematol. 2019 Sep;8(3):121-124. doi: 10.14740/jh543. Epub 2019 Sep 30. J Hematol. 2019. PMID: 32300455 Free PMC article.
Antiplatelet and anticoagulant therapies in hereditary hemorrhagic telangiectasia: A large French cohort study (RETROPLACOTEL).
Grobost V, Hammi S, Pereira B, Guilhem A, Duffau P, Seguier J, Parrot A, Gautier G, Alric L, Kerjouan M, Le Guillou X, Simon D, Chaussavoine L, Rondeau-Lutz M, Leguy-Seguin V, Delagrange L, Lavigne C, Maillard H, Dupuis-Girod S; French HHT group. Grobost V, et al. Among authors: leguy seguin v. Thromb Res. 2023 Sep;229:107-113. doi: 10.1016/j.thromres.2023.07.001. Epub 2023 Jul 6. Thromb Res. 2023. PMID: 37437516
27 results